Advertisement

Endomyocardial Biopsy

  • Lisa Bergersen
  • Susan Foerster
  • Audrey C. Marshall
  • Jeffery Meadows

Abstract

The most common indication for an endomyocardial biopsy (EMB) is surveillance for post–heart transplant cellular rejection. Another frequent indication is in idiopathic cardiomyopathies, as a guide for therapy (myocarditis vs. cardiomyopathy) or for prognostic purposes (cardiomyopathy, glycogen storage disease, metabolic disorders).

Keywords

Femoral Vein Tricuspid Valve Glycogen Storage Disease Endomyocardial Biopsy Complex Congenital Heart Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hauptman PJ, Gass A, Cohen M et al. Endomyocardial biopsy: advantages of adding a posterior bend to the bioptome. Cathet Cardiovasc Diagn 1992;27: 228–229.PubMedCrossRefGoogle Scholar
  2. 2.
    Pophal SG, Sigfusson G, Booth KL et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999;34(7):2105–2110.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Lisa Bergersen
    • 1
  • Susan Foerster
    • 2
  • Audrey C. Marshall
    • 1
  • Jeffery Meadows
    • 3
  1. 1.Department of CardiologyChildren’s Hospital BostonBostonUSA
  2. 2.Washington University in St. LouisSt. LouisUSA
  3. 3.Division of Pediatric CardiologyUniversity of California at San FranciscoSan FranciscoUSA

Personalised recommendations